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Abstract
Aging is associated with a paradox of immunodeficiency and inflammation (an evidence of
hyperactive immune system). Apoptosis is associated with cellular depletion and suppression of
inflammatory response. In this brief review, we will present evidence for the role of increased
apoptosis in immunodeficiency and paradoxical increased inflammation associated with human
aging. In particular, a role of apoptotic cells in failure to generate anti-inflammatory responses and
directly activating inflammatory responses will be discussed.
Introduction
Aging represents a paradox of immune deficiency and
chronic inflammation. Immune deficiency is predomi-
nantly associated with progressive decline in T cell func-
tions in both mice and humans and numbers in humans
[1-11], whereas, chronic inflammation is evidenced by
increased circulating levels of pro-inflammatory
cytokines, (IL-6, TNF-α, IL-1β,), acute phase proteins
including C-reactive protein and serum amyloid A, and
increased frequency of chronic inflammatory diseases of
aging such as Alzheimer's Parkinson's diseases, amyo-
trophic lateral sclerosis, atherosclerosis etc. [12-19].
Apoptosis is a physiological form of programmed cell
death which plays an important role in cellular homeos-
tasis in the immune system in the selection of T cell reper-
toire, deletion of self-reactive lymphocytes, and cytotoxic
response against target cells [20]. One of the features of
apoptosis is that the cell death is associated with lack of
inflammatory response (c.f. necrosis). Apoptosis is associ-
ated with blebbing of plasma membrane and the develop-
ment of apoptotic bodies, which contain nuclear and
cytoplasmic contents that are readily taken up by neigh-
boring phagocytic cells. Apoptotic bodies inhibit inflam-
matory response of phagocytic cells by inducing anti-
inflammatory cytokines [21,22]. We and others have
demonstrated that human T cells and T cell subsets from
aged humans display increased sensitivity to death recep-
tor-induced apoptosis [23-28], which may play an impor-
tant role in T cell deficiency associated with aging. In
disease states, including aging which is associated with
increased apoptosis we would expect that increased apop-
totic bodies would be taken-up by the neighboring phago-
cytic cells and inhibit pro-inflammatory response.
However, aging is associated with chronic inflammatory
state. In this review we will discuss a role of increased
apoptosis of various subsets of CD4+ and CD8+ T cells in
immunodeficiency associated with aging and the role of
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apoptotic bodies in failure to suppress pro-inflammatory
response in dendritic cells as one of the mechanisms of
chronic inflammation associated with human aging.
Apoptosis
Apoptosis is mediated by two major pathways, the extrin-
sic or death receptor-mediated pathway and the intrinsic
pathway, which is mediated via mitochondria and the
endoplasmic reticulum (Figure 1; [29-34]). In aging,
death receptor pathway of apoptosis has been extensively
examined; however, mitochondrial and the endoreticu-
lum pathways of apoptosis in aging have not been studied
in detail. Therefore, we will focus our discussion on death
receptor-mediated apoptosis in human aging. Death
receptors belong to a large family of tumor necrosis factor
receptors (TNFRs). Following interaction with death
receptor ligand, the cytoplasmic death domains (DD) of
death receptors undergo trimerization. Since cytoplasmic
domains of death receptors lack enzymatic activity they
recruit a set of adaptor proteins by protein-protein inter-
action and proximal or initiator caspases (caspase-8, cas-
pase-10) forming a death-inducing signaling complex
(DISC). Caspases are present in an inactivated prozyme
form. In the DISC, initiator caspases are activated by
homodimerization and without undergoing cleavage and
are released from the disc into the cytoplasm where they
serve as enzymes for effector pro-caspases (caspase-3, cas-
pase-6, and caspase-7). Initiator caspases cleave effector
pro-caspase to generate active effector caspase, which
cleave a large number of cytoplasmic and nuclear sub-
strates to induce morphological and biochemical features
of apoptosis [31]. Among cell death receptors CD95- and
TNFR-mediated apoptosis has been extensively studies.
CD95 is constitutively expressed on a subset of T cells and
is upregulated following activation; CD95L is lacking on
resting T cells and is induced upon activation. CD95L is
also proteolytically cleaved and may be present in the sol-
uble form in the serum. Interaction between CD95 and
soluble CD95L or anti-CD95 antibody results in trimeri-
zation of cytoplasmic death domain of CD95 [20,29].
CD95 DD recruits an adaptor protein, the fas-associated
death domain (FADD), which contain a death effector
domain. FADD then recruits procaspase-8 to form DISC.
Pro-caspase-8 is autolytically activated and is released into
the cytoplasm where it activates effector caspases (a point
of no return) to induced apoptosis.
TNF-α induces signaling via both TNFR-1 and TNFR-2.
TNFR-1 contains DD and induces both survival and cell
death signals, whereas TNFR-2 lack cytoplasmic DD and
predominantly provides survival signal; however, may
enhance apoptosis-mediated by TNFR-1 [34-38].
Recently, Tschopps and his associated have suggested two
complex model for TNF-α-induced activation of NF-κB
(Figure 2), which provides a survival signal and caspase
activation and also provides an apoptotic signal [39]. In
this model, an interaction between TNF-α and TNFR-1,
results in trimerization of DD of TNFR-I, which in turn
recruits an adaptor protein, the TNFR-associated death
domain (TRADD). TRADD then recruits TNFR-associated
factor-2 (TRAF-2) and (receptor interacting protein (RIP)
forming signaling complex I (within minutes), which
results in the activation of NF-κB. Signaling complex 1
activates NF-κB via recruitment of IκB kinase (IKK) com-
plex and phosphorylation of IκB, which is a signal for
ubiquitination and subsequent proteasomal degradation
of IκB resulting in the release of NF-κB and its transloca-
tion and binding to DNA to induce production of a
number of anti-apoptotic proteins [40-43]. The signaling
complex 2 is formed possibly following TNFR-1 internal-
ization (>2 hours following interaction between TNF-α
and TNFR-1), resulting in the dissociation from RIP, and
TRAF-2 from TNFR-1and recruitment of FADD and cas-
pase-8 forming a DISC and finally activation of effector
caspases and induction of apoptosis. When NF-κB activa-
tion is strong, anti-apoptotic proteins inhibit activation of
casapse activation in complex II; however, a weak com-
plex I signaling results in weak or deficient NF-κB activa-
tion. As a result the products of anti-apoptotic genes are
not made (at least in normal quantity) and complex II can
signal apoptosis via activation of caspases. There is an evi-
dence that TRAF-2 also activate JNK-2 (via activation of
MEKK1), which cleaves Bid into jBid (distinct from tBid,
which is a product of caspase-8 cleavage). jBid translo-
cates to the mitochondria and preferentially releases
Smac/Diablo from the mitochondria, which may disrupt
TRAF-2/cIAP1 (cellular Inhibitor of Apoptosis Protein 1)
complex formation and inhibition of caspase activation
[44,45]. In addition, Diablo inhibits anti-apoptotic effects
of cIAP and XIAP by binding to them.
Apoptosis of T cell subsets in aging
Unlike mice, human aging is associated with lymphope-
nia which is shared by both CD4+ and CD8+ T cells
[46,47], which may play a role in increased frequency of
infections and malignancies in aging. We and others have
reported increased apoptosis in T cells, CD4+ and CD8+ T
cells in human aging. These have been recently reviewed
and readers are referred to recent reviews [25,48].
Several investigators have reported increased sensitivity of
T cells from aged humans to activation-induced cell death
(AICD), which is mediated via CD95-CD95L interaction
[26,27]. We have observed increased sensitivity of both
CD4+ and CD8+ T cells from aged humans to CD95-
mediated apoptosis, which is associated with increased
activation of caspase-8 and caspase-3 [23,49]. Further-
more, we observed increased expression of FADD.Immunity & Ageing 2006, 3:5 http://www.immunityageing.com/content/3/1/5
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We have examined TNF-α-induced apoptosis in T cells
and T cell subsets in aging. Previously we have reported
that both CD4+ and CD8+ T cells from aged humans dis-
play increased sensitivity to TNF-α-induced apoptosis
[24]. Furthermore, we demonstrated that signaling down-
stream of TNFR-1 was involved [25]. We showed that
increased sensitivity of aged T cells to TNF-α-induced
apoptosis was associated with decreased NF-κB activation
due to decreased phosphorylation of both IKKβ and IκB
[50], decreased expression of cIAPs [51], and increased
expression of FADD [52]. Overexpression of dominant
negative FADD in aged T ells resulted in normalization of
apoptosis to the level observed in T cells from young sub-
jects. Similarly overexpression of IKK resulted in upregu-
lation of cIAP, increased phosphorylation of IκB, and
inhibition of apoptosis in aged T cells to a level observed
with young T cells, suggesting that decreased NF-κB plays
an important role in increased sensitivity of aged T cells to
apoptosis [50,51]. Several other investigators have also
reported decreased NF-κB activation in T cells in aging
[53,54].
More recently, we have analyzed TNF-α-induced apopto-
sis in naïve and different memory T cells. Following acti-
vation with an antigen, naïve T cells undergo clonal
expansion and following clearance of antigen majority of
antigen-specific T cells are removed by apoptosis and a
small pool of antigen-specific T cells are retained as mem-
ory T cell pool. Based upon their homing characteristics,
cytokine production, and effector functions memory T
Death receptor and intrinsic pathways of apoptosis Figure 1
Death receptor and intrinsic pathways of apoptosis. Intrinsic pathway is mediated by mitochondrial and the endoplasmic retic-
ulum pathways. Distinct initiator caspases are activated in each pathway of apoptosis (modified from ref. 94).
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cells have been further subdivided into central memory
(TCM, which localized to lymph nodes and demonstrate
high replicative potentials) and effector memory (TEM,
which are localized in non-lymphoid tissues and display
poor proliferative potential) T cells [55-58]. These subsets
are identified by the presence and absence of a set of cell
surface markers. CD8+ effector memory T cells are further
subdivided into two subsets TEM (CD45RA-) and TEMRA
(CD45RA+), whereas CD4+ effector memory cells are pri-
marily TEM and only 1–2% are TEMRA; however, they are
increased in aging [48]. In human aging, the number of TN
and TCM CD8+ T cells is significantly reduced, whereas the
numbers of TEMRA CD8+ T cells is increased [59-62]. We
have shown that naïve (TN) and TCM CD8+ T cells are sen-
sitive to TNF-α-induced apoptosis, whereas TEM and TEMRA
CD8+ T cells are relatively resistant to apoptosis. Further-
more, TN and TCM CD8+ T cells from aged humans are sig-
nificantly more sensitive to TNF-α-induced apoptosis as
compared to those from young subjects, which may be
responsible, at least in part, for decreased TN and TCM in
aging [63]. However, no significant difference was
observed in TNF-α-induced apoptosis in TEM or TEMRA
CD8+ T cells between young and aged subjects. We have
observed that TEMRA CD8+ T cells preferentially proliferate
in response to IL-15 as compared to naïve and TCM CD8+
T cells, which proliferate preferentially in response to IL-7
(unpublished observations). Furthermore, in our gene
array analysis of CD8+ T cells from aged ad young subjects
by Affymatrix we have observed upregulation of IL-15
gene in CD8+ T cells in aged humans (unpublished obser-
TNF receptor (TNFR) pathway of signaling Figure 2
TNF receptor (TNFR) pathway of signaling. Two complex model is shown. Upon ligation with TNF-α (with in 10–20 min), 
TNFR I undergo trimerization and recruits various adapter molecules resulting in the activation of NF-κB, which induces sev-
eral anti-apoptotic genes (Complex I formation) and survival signal. This is followed by (more than 2–3 hours) by an endocyto-
sis of receptor complex resulting in the dissociation of certain adapter proteins (TRAF-2, RIP) and recruitment of fas – 
associated death domain (FADD) and procasepase-8 to form death-inducing signaling complex (DISC). In the DISC, caspase-8 
is activated and released into the cytoplasm where it activates effector caspases to induce apoptosis.
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vation). This would suggest that the accumulation of
TEMRA CD8+ T cells in aging is not due to changes in apop-
tosis and may be due to increased growth secondary to
increased IL-15 in aging. Berard et al [64] have reported
that IL-15 promotes survival of naïve and memory CD8+
T cells (based upon the expression of CD44) in mice.
However, these investigators did not characterized mem-
ory CD8+ T cells into TCM and TEM cells. Dunne et al [65]
reported that following acute Epstein-Barr virus infection,
CD45RA+ CD8+ T cells (most likely TEMRA, although these
investigators did not use other markers to confirm that
these cells are indeed TEMRA) proliferate in response to IL-
15. These investigators did not compare the effect of IL-15
on TCM and TN CD8+ T cells.
We have investigated the molecular basis of increased sen-
sitivity of TNand TCM CD8+ T cells from aging subjects to
TNF-α-induced apoptosis. TNFR-1 and TNFR-2 expres-
sion on TN and TCM>CD8+ T cells is similar between young
and aged subjects [63], suggesting that downstream sign-
aling events are likely responsible for increase sensitivity
to apoptosis. Therefore, we have compared downstream
signaling molecules in TNFR signaling pathway between
young and aged humans (unpublished data). TNF-α-
induced NF-κB activation in TN and TCM CD8+ T cells in
aging is reduced as compared to young subjects. Further-
more, we observed that TNF-α-induced JNK activation of
reduced, suggesting that TNFR-mediated mitochondrial
pathway (via activation of jBid) is unlikely responsible for
increased sensitivity to apoptosis. Since activation of IKK
complex and phosphorylation of IκB are necessary for the
activation of NF-κB [42,43], we examined TNF-α-induced
phosphorylation of IKKα/β and of IκB. CD8+CD28+ T
cells (TN plus TCM) from aged subjects had significantly
lower phosphorylation of both IKKα/β and IκB as com-
pared to young controls. IKK complex is activated by
TRAF-2 via RIP and NIK [66-68]. In aged CD8+CD28+ T
cells the expression of TRAF-2, RIP, and NIK was
decreased as compared to young subjects. NF-κB mediates
its survival signaling by inducing production of anti-
apoptotic proteins, including Gadd45β, Bcl-xL, A20, IAPs,
and FLIP [69,70]. Gadd45β inhibits apoptosis by inhibit-
ing JNK activation [71]. Furthermore, Bcl-xL  regulates
apoptosis by inhibiting mitochondrial pathway of apop-
tosis. Since in aged TN and TCM CD8+ T cells JNK activation
is decreased, it is unlikely that mitochondrial pathway of
apoptosis and therefore, Gadd45β and Bcl-xL play a signif-
icant role increased sensitivity to TNF-α-induced apopto-
sis. We have observed decreased expression of cIAP1,
FLIP, and A20 in TN and TCM CD8+ T cells in aged subjects
as compared to young subjects. Which of these NF-κB tar-
get anti-apoptotic genes play a role in increased sensitivity
of TN and TCM CD8+ T cells in aging remains to be deter-
mined? A similar pattern of apoptosis though not as strik-
ing as in CD8+ subsets has been observed with CD4+ T
cells [48]. A model of proposed mechanisms of increased
TNF-α-induced apoptosis in TN and TCM CD8+ T cells in
aging is shown in Figure 3.
Proposed mechanisms of increased sensitivity of aged TN and TCM CD8+ T cells to TNF-α-induced apoptosis Figure 3
Proposed mechanisms of increased sensitivity of aged TN and TCM CD8+ T cells to TNF-α-induced apoptosis. Signaling mole-
cules downstream of TNFRs that activate NF-κB are decreased in aging resulting in decreased NF-κB activity and decreased 
expression of anti-apoptotic proteins.Immunity & Ageing 2006, 3:5 http://www.immunityageing.com/content/3/1/5
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Role of apoptotic cells in the regulation of 
inflammation and changes in aging
Apoptotic cell death and clearance of dead cells is of vital
importance in developing and maintaining the normal
tissue homeostasis and resolution of inflammation. The
most remarkable aspect of the process of cell death is the
targeted elimination of apoptotic cells without inflamma-
tion or pathology. There is growing evidence that the
clearance of apoptotic cells by phagocytosis can result in
anti-inflammatory and immunosuppressive effects [72].
This is supported by the observations that the defective
clearance of apoptosis is associated with autoimmunity
and inflammation [73]. Co-culture of apoptotic cells with
macrophages results in an active suppression of proin-
flammatory cytokines, including TNF-α, whereas the pro-
duction of anti-inflammatory transforming growth factor-
β (TGF-β) and IL-10 is increased [21,22]. Further studies
have revealed that TGF-β1, PGE2 and platelet activating
factor (PAF) all have paracrine/autocrine role in inhibit-
ing TNF-α secretion [74]. Cells that have undergone apop-
tosis without being phagocytosed undergo secondary
necrosis, releasing some of its contents, including heat
shock proteins, which interact with Toll-like receptors on
antigen presenting cells (APC) to induce inflammatory
cytokines. In addition, apoptotic cells can directly induce
caspase-1-mediated release of pro-inflammatory IL-1 and
IL-8 from the dying cells [75,76].
In summary, under normal conditions, clearance of apop-
totic cells by phagocytic cells is associated with secretion
of anti-inflammatory cytokines, including IL-10 and TGF-
β1 resulting in the inhibition of inflammation. However,
under pathological conditions associated with excessive
apoptosis and/or decreased clearance of apoptotic cells,
apoptotic cells may directly induce caspase-1 dependent
secretion of IL-1β and IL-8 or undergo secondary necrosis
to induce secretion of other pro-inflammatory cytokines,
including TNF-α by macrophages via release of endog-
enous ligands (e.g. heat shock proteins) for TLR.
Dendritic cells (DCs) are the professional antigen present-
ing phagocytes. Immature dendritic cells are capable of
large scale phagocytosis of apoptotic cells by a mechanism
that involve bridging of thrombospondin 1 (TSP1) and
DC integrins and CD36 [77,78] The maturation of imma-
ture DCs by LPS and other stimuli can be inhibited by
engulfment of apoptotic cells as evidenced by the sup-
pressed upregulation of key co-stimulatory molecule
CD86 [79-82] and the reduced expression of IL-12 by
DCs. DCs on stimulation with LPS in the presence of
apoptotic cells secrete decreased amounts of TNF-α and
IL-12 [79-81]. However, in contrast to macrophages TGF-
β and IL-10 production by DCs is not increased following
ingestion of apoptotic cells. Therefore, phagocytosis of
apoptotic cells by DCs inhibits secretion of pro-inflamma-
tory cytokines by an unknown mechanism, which is inde-
pendent of TGF-β1 and IL-10. The maturation state of
DCs acts as a checkpoint in the initiation of immunity and
inflammation. Immature DCs are highly phagocytic,
express low levels of MHC and co-stimulatory molecules
and do not produce inflammatory cytokines. Maturation
of DCs is associated with downregulation of phagocytic
capacity, upregulation of MHC and co-stimulatory mole-
cules, and secretion of pro-inflammatory cytokines.
Aging maybe considered a "chronic inflammatory" condi-
tion as evidenced by elevated levels of circulatory pro-
inflammatory cytokines, including IL-6, TNF-α, PGE-3,
and anti-inflammatory mediators, such as IL-1 receptor
antagonists, soluble TNFRs and acute phase proteins, in
elderly subjects [17,83] However, the mechanisms under-
lying this chronic inflammatory state and increased pro-
inflammatory cytokines in aging in presently unclear. Sev-
eral studies regarding a role of macrophages and T cells in
elevated levels of pro-inflammatory cytokines in aging has
produced conflicting data [17]. We have investigated a
role of DCs, especially in relation to uptake of apoptotic
cells and regulation of inflammatory response in aging.
We have observed that DCs from aged humans display a
more mature phenotype (increased MHC and co-stimula-
tory molecule), decreased capacity to phagocytose apop-
totic lymphocytes, and increased production of pro-
inflammatory cytokines TNF-α and IL-6 as compared to
DCs from young subjects (unpublished data). Unlike DCs
from young subjects, co-culture of apoptotic cells with
LPS-stimulated DCs from aged subjects failed to Inhibit
secretion of IL-6 and TNF-α, therefore contributing to an
increased pro-inflammatory cytokine production by DCs
from aged subjects. Furthermore, we have observed that
LPS-stimulated DCs from aged subjects in the absence of
apoptotic cells also secrete higher levels of IL-6 and TNF-
α as compared to young subjects. Inefficient clearance of
apoptotic cells by aged DCs may lead to extracellular accu-
mulation of apoptotic cells and subsequent secondary
necrosis of apoptotic cells, which may induce maturation
and activation of DCs via production of endogenous dan-
ger signals (e.g. heat shock protein) to induce pro-inflam-
matory cytokine production. Furthermore, extracellular
apoptotic cells may also trigger caspase-1-mediated secre-
tion of IL-1β and IL-18 from dying cells. Mature pheno-
type DCs in aged subjects may sample self antigens from
extracellularly accumulated apoptotic cells and from
those undergone secondary necrosis to induce autoim-
mune response. Therefore, more mature phenotype of
DCs and inefficient clearance of apoptotic cells may result
in both chronic inflammation and autoimmunity, two
features commonly observed in aging
Therefore, we propose that apoptosis plays an important
role in the pathogenesis of chronic inflammation duringImmunity & Ageing 2006, 3:5 http://www.immunityageing.com/content/3/1/5
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human aging by two mechanisms, [1] a defective clear-
ance of apoptotic cells as a result of poor phagocytosis of
apoptotic cells by aged DCs results in secondary necrosis
and release of endogenous ligands for TLRs to activate
DCs to differentiate into more mature phenotype and
secrete pro-inflammatory cytokines (e.g. TNF-α and IL-6)
and [2] increased number of apoptotic lymphocytes in
aged humans may directly trigger caspase-1-mediated IL-
1β and IL-8 release from dying cells.
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